ATE240743T1 - Verfahren und substanzen gegen protozoen - Google Patents
Verfahren und substanzen gegen protozoenInfo
- Publication number
- ATE240743T1 ATE240743T1 AT95925597T AT95925597T ATE240743T1 AT E240743 T1 ATE240743 T1 AT E240743T1 AT 95925597 T AT95925597 T AT 95925597T AT 95925597 T AT95925597 T AT 95925597T AT E240743 T1 ATE240743 T1 AT E240743T1
- Authority
- AT
- Austria
- Prior art keywords
- substances against
- against protozoa
- protozoa
- protozoan
- bacteriocidal
- Prior art date
Links
- 239000000126 substance Substances 0.000 title 1
- 208000010362 Protozoan Infections Diseases 0.000 abstract 2
- 230000001939 inductive effect Effects 0.000 abstract 1
- 230000035699 permeability Effects 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A61K38/1751—Bactericidal/permeability-increasing protein [BPI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/12—Fertilization attaching inhibition
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/273,470 US5646114A (en) | 1994-07-11 | 1994-07-11 | Anti-protozoan methods |
PCT/US1995/008624 WO1996001647A1 (en) | 1994-07-11 | 1995-07-11 | Anti-protozoan methods and materials |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE240743T1 true ATE240743T1 (de) | 2003-06-15 |
Family
ID=23044078
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95925597T ATE240743T1 (de) | 1994-07-11 | 1995-07-11 | Verfahren und substanzen gegen protozoen |
Country Status (9)
Country | Link |
---|---|
US (3) | US5646114A (de) |
EP (1) | EP0769959B1 (de) |
JP (1) | JPH10502642A (de) |
AT (1) | ATE240743T1 (de) |
AU (1) | AU2967595A (de) |
CA (1) | CA2194895A1 (de) |
DE (1) | DE69530844D1 (de) |
WO (1) | WO1996001647A1 (de) |
ZA (1) | ZA955740B (de) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5652332A (en) * | 1993-03-12 | 1997-07-29 | Xoma | Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
US6271203B1 (en) | 1994-07-07 | 2001-08-07 | Xoma Corporation | Anti-protozoan methods and materials |
US5646114A (en) | 1994-07-11 | 1997-07-08 | Xoma Corporation | Anti-protozoan methods |
AU727085B2 (en) * | 1995-07-20 | 2000-11-30 | Xoma Corporation | Anti-fungal peptides |
WO1997042966A1 (en) | 1996-05-10 | 1997-11-20 | Xoma Corporation | Therapeutic uses of bpi protein products for human meningococcemia |
US5741779A (en) * | 1996-05-10 | 1998-04-21 | Xoma Corporation | Antithrombotic materials and methods |
CA2255539C (en) * | 1996-05-23 | 2005-09-27 | Xoma Corporation | Therapeutic uses of bpi protein products in humans with hemorrhage due to trauma |
US5888973A (en) * | 1996-08-09 | 1999-03-30 | Xoma Corporation | Anti-chlamydial uses of BPI protein products |
US6482796B2 (en) * | 1996-11-01 | 2002-11-19 | Xoma Corporation | Therapeutic uses of N-terminal BPI protein products in ANCA-positive patients |
NZ335401A (en) * | 1996-11-01 | 2000-12-22 | Xoma Corp | Therapeutic uses of BPI protein products in cystic fibrosis patients |
US6093573A (en) * | 1997-06-20 | 2000-07-25 | Xoma | Three-dimensional structure of bactericidal/permeability-increasing protein (BPI) |
US6013631A (en) * | 1998-06-19 | 2000-01-11 | Xoma Corporation | Bactericidal/permeability-increasing protein (BPI) deletion analogs |
DE60002552T2 (de) * | 1999-01-22 | 2004-02-26 | Xoma Technology Ltd., Berkeley | Verwendung von einem bpi protein zur herstellung eines medikamentes zur behandlung von chronischen herzerkrankungen |
US6875584B1 (en) * | 1999-03-02 | 2005-04-05 | University Of Georgia Research Foundation, Inc. | Prophylactic and therapeutic immunization against protozoan infection and disease |
US6955908B1 (en) * | 2000-06-21 | 2005-10-18 | Lambl Barbara B | Organism associated with nongonococcal urethritis |
WO2002055099A2 (en) * | 2000-12-01 | 2002-07-18 | Xoma Technology Ltd | Modulation of pericyte proliferation using bpi protein products or bpi inhibitors |
EP1741440A1 (de) | 2005-07-08 | 2007-01-10 | Mellitus S.L. | Verwendung von BPI-proteine zur Behandlung von stoffwechselbedingten Erkrankungen und Herzkreislaufstörungen |
EP2595634B1 (de) * | 2010-07-23 | 2016-09-14 | Acea Biotech, Inc. | Antimykotische und antiparasitäre polyenmakrolide |
GB201319620D0 (en) | 2013-11-06 | 2013-12-18 | Norwegian University Of Science And Technology | Immunosuppressive agents and their use in therapy |
GB201319621D0 (en) | 2013-11-06 | 2013-12-18 | Norwegian University Of Science And Technology | Antimicrobial agents and their use in therapy |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5198541A (en) * | 1987-08-11 | 1993-03-30 | New York University | Dna encoding bactericidal/permeability-increasing proteins |
US5217956A (en) * | 1988-10-21 | 1993-06-08 | The Children's Hospital Of Philadelphia | Composition and treatment with biologically active peptides and certain anions |
US5089274A (en) * | 1989-02-14 | 1992-02-18 | Incyte Pharmaceuticals, Inc. | Use of bactericidal/permeability increasing protein or biologically active analogs thereof to treat endotoxin-related disorders |
US5334584A (en) * | 1989-02-14 | 1994-08-02 | Incyte Pharamaceuticals, Inc. | Recombinant, non-glycosylated bpi protein and uses thereof |
US5171739A (en) * | 1989-02-14 | 1992-12-15 | Incyte Pharmaceuticals, Inc. | Treatment of endotoxin-associated shock and preventation thereof using a BPI protein |
US5234912A (en) * | 1989-02-14 | 1993-08-10 | Incyte Pharmaceuticals, Inc. | Pharmaceutical compositions comprising recombinant BPI proteins and a lipid carrier and uses thereof |
US5308834A (en) * | 1989-02-14 | 1994-05-03 | Incyte Pharmaceuticals, Inc. | Treatment of endotoxin-associated shock and prevention thereof using a BPI protein |
EP0563222B1 (de) * | 1990-12-03 | 1998-02-25 | New York University | Biologisch aktive bakterizide/permeabilitätserhöhende proteinbruchstücke |
EP0605653A4 (de) * | 1991-09-26 | 1995-03-15 | Incyte Pharma Inc | Neue art eines liposaccharid bindendes protein (lbp). |
US5234822A (en) * | 1991-10-17 | 1993-08-10 | New England Medical Center Hospitals, Inc. | Trypanosoma cruzi heparin-binding protein and antibodies thereto |
CA2276548C (en) * | 1992-05-19 | 2001-07-31 | Xoma Corporation | Improved methods for the preparation of endotoxin-binding proteins |
WO1993023434A2 (en) * | 1992-05-19 | 1993-11-25 | Xoma Corporation | Bpi-immunoglobulin fusion proteins |
US5420019A (en) * | 1993-02-02 | 1995-05-30 | Xoma Corporation | Stable bactericidal/permeability-increasing protein muteins |
CN1163264C (zh) * | 1993-02-02 | 2004-08-25 | 爱克索马技术有限公司 | 改进的药物组合物 |
CN1105574C (zh) * | 1993-03-12 | 2003-04-16 | 爱克索马技术有限公司 | 杀菌/增强通透性蛋白质产物的治疗用途 |
US5348942A (en) * | 1993-03-12 | 1994-09-20 | Xoma Corporation | Therapeutic uses of bactericidal/permeability increasing protein products |
CA2157925C (en) * | 1993-03-12 | 2000-06-06 | Lewis H. Lambert, Jr. | Treatment of mycobacterial diseases by administration of bactericidal/permeability-increasing protein products |
US5646114A (en) | 1994-07-11 | 1997-07-08 | Xoma Corporation | Anti-protozoan methods |
US6271203B1 (en) | 1994-07-07 | 2001-08-07 | Xoma Corporation | Anti-protozoan methods and materials |
-
1994
- 1994-07-11 US US08/273,470 patent/US5646114A/en not_active Expired - Fee Related
-
1995
- 1995-07-11 JP JP8504455A patent/JPH10502642A/ja not_active Withdrawn
- 1995-07-11 AT AT95925597T patent/ATE240743T1/de not_active IP Right Cessation
- 1995-07-11 EP EP95925597A patent/EP0769959B1/de not_active Expired - Lifetime
- 1995-07-11 WO PCT/US1995/008624 patent/WO1996001647A1/en active IP Right Grant
- 1995-07-11 ZA ZA955740A patent/ZA955740B/xx unknown
- 1995-07-11 CA CA002194895A patent/CA2194895A1/en not_active Abandoned
- 1995-07-11 AU AU29675/95A patent/AU2967595A/en not_active Abandoned
- 1995-07-11 DE DE69530844T patent/DE69530844D1/de not_active Expired - Lifetime
-
1997
- 1997-07-07 US US08/888,876 patent/US6013629A/en not_active Expired - Lifetime
-
2001
- 2001-06-08 US US09/878,546 patent/US6440936B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU2967595A (en) | 1996-02-09 |
WO1996001647A1 (en) | 1996-01-25 |
US20010029245A1 (en) | 2001-10-11 |
JPH10502642A (ja) | 1998-03-10 |
ZA955740B (en) | 1997-01-07 |
EP0769959A1 (de) | 1997-05-02 |
EP0769959B1 (de) | 2003-05-21 |
US5646114A (en) | 1997-07-08 |
CA2194895A1 (en) | 1996-01-25 |
DE69530844D1 (de) | 2003-06-26 |
US6013629A (en) | 2000-01-11 |
US6440936B2 (en) | 2002-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE240743T1 (de) | Verfahren und substanzen gegen protozoen | |
DE69716605D1 (de) | Anti-chlamydia verfahren und mittel | |
DE69526216D1 (de) | Antifungaleverfahren und mitteln | |
BR9502707A (pt) | Composto composição farmacêutica e método para o tratamento de uma afecção | |
ATE348113T1 (de) | Rekombinanter anti-cd4 antikörper zur menschlichen behandlung | |
PT966447E (pt) | Moleculas pequenas uteis no tratamento de doencas inflamatorias | |
FR12C0004I1 (de) | ||
ES2170104T3 (es) | Inhibidores de la produccion de proteinas de beta-amiloide. | |
DE69727142D1 (de) | Verwendung eines bpi proteinproduktes als antithrombotisches mittel | |
BG101118A (en) | Therapeutical compounds | |
BR9707819A (pt) | Imunogenos peptidicos | |
DE69410254D1 (de) | Behandlung von mycobakteriellen erkrankungen durch verabreichung von bakrerientötende, durchlässigkeitserhöhende proteinfragmente | |
DE69635582D1 (de) | Diagnostika und behandlungen von peridontalen erkrankungen | |
DK1082131T3 (da) | Immunoregulator | |
DE69631282D1 (de) | Blutverarbeitungssystem und verfahren | |
ATE199321T1 (de) | Anti idiotypische antikörper gegen gonococcen und diese verwendende verfahren und zusammensetzungen. | |
FI965114A0 (fi) | Farmaseuttinen koostumus virusinfektioiden sekä valinnaisesti tulehdusten estoon ja (tai) hoitoon sekä niiden hoitomenetelmä | |
FI963638A0 (fi) | Menetelmiä HIV-1-injektion diagnosoimiseksi ja hoitamiseksi | |
ATE261724T1 (de) | Antikonvulsive derivate zur behandlung von posttraumatischen stresserkrankungen | |
GR3033698T3 (en) | Use of a hymenoptera venom for the manufacture of a medicament for treating dna virus infections. | |
DE69734890D1 (de) | Rdgb-proteine | |
DE59608075D1 (de) | Intrakorporales behandlungssystem | |
ATA93695A (de) | Mittel zur behandlung von strahlenschäden | |
BR9205877A (pt) | Processo e composiçao para o tratamento de infecçoes por herpes. | |
DE59611353D1 (de) | Transketolase-verwandtes protein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |